• Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome

    Jun 1, 2010, 00:00

  • Modeling Complex Treatment Strategies- Construction and Validation of a Discrete Event Simulation Model for Glaucoma

    Jun 1, 2010, 00:00

  • Assessing Outcomes in Liver Disease Patients- Reliability and Validity of the Spanish Version of the Liver Disease Quality of Life Questionnaire (LDQOL 1.0)

    Jun 1, 2010, 00:00

  • Comparative Assessment for Medications and Devices- Apples and Oranges?

    Jun 1, 2010, 00:00

  • Reflecting Heterogeneity in Patient Benefits- The Role of Subgroup Analysis with Comparative Effectiveness

    Jun 1, 2010, 00:00

  • Response to the Letter from Ms. Tamzin Furtado

    Jun 1, 2010, 00:00

  • Contemporary Challenges in Deriving Summary Estimates of Comparative Effectiveness Using Meta-Analysis

    Jun 1, 2010, 00:00

  • Transferability of Model-Based Economic Evaluations- The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands

    Jun 1, 2010, 00:00

  • Health Technology Assessment in the United Kingdom

    Jun 1, 2010, 00:00

  • The Suitability of Polycystic Ovary Syndrome-Specific Questionnaires for Measuring the Impact of PCOS on Quality of Life in Clinical Trials

    Jun 1, 2010, 00:00

  • PSY25 COST-EFFECTIVENESS OF NONINVASIVE MAGNETIC RESONANCE DIRECT THROMBUS IMAGING AND ULTRASONOGRAPHY FOR DIAGNOSING DISTAL DEEP VEIN THROMBOSIS

    May 1, 2010, 00:00

  • PCN68 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCN22 DO GAPS IN TREATMENT CONTINUATION OF DOCETAXEL AFFECT OVERALL SURVIVAL? - RESULTS FROM A US LOCAL COMMUNITY PRACTICE

    May 1, 2010, 00:00

  • PCN149 ELECTRONIC MEDICAL RECORDS- QUALITY CANCER CARE AND COST-EFFECTIVENESS

    May 1, 2010, 00:00

  • PMS33 PARTICIPATION, SATISFACTION AND KNOWLEDGE LEVEL AMONG PSORIATIC ARTHRITIS AND CUTANEOUS PSORIASIS PATIENTS

    May 1, 2010, 00:00

  • PND14 COST-UTILITY ANALYSIS ON HYPOTHETICAL NEUROIMAGING TRACER FOR DIAGNOSIS OF DEMENTIA OF ALZHEIMER TYPE IN JAPAN

    May 1, 2010, 00:00

  • PSY59 USING PATIENT FOCUS GROUPS TO INFORM ECONOMIC MODELING- EXPERIENCE FROM A HEMOPHILIA PATIENT FOCUS GROUP

    May 1, 2010, 00:00

  • PHP20 PSYCHOTROPIC DRUG UTILIZATION PATTERNS AMONG ELDERLY NURSING HOME RESIDENTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP91 DRUGS PRESCRIBING INDICATORS IN SECOND AND THIRD-LEVEL COMPLEXITY HOSPITALS FROM COLOMBIA

    May 1, 2010, 00:00

  • PCN63 THE COST-EFFECTIVENESS OF MOHS MICROGRAPHIC SURGERY VERSUS SURGICAL EXCISION FOR THE TREATMENT OF NONMELANOMA SKIN CANCER

    May 1, 2010, 00:00

  • PCN15 STATIN USE AND THE RISK OF COLORECTAL CANCER- A POPULATION-BASED COHORT STUDY

    May 1, 2010, 00:00

  • PCN56 COSTS ASSOCIATED TO THE TREATMENT OF DIFFERENT STAGES OF MEXICAN BREAST CANCER PATIENTS

    May 1, 2010, 00:00

  • PMC17 A COMPARISON OF THE DISCRIMINTATIVE AND EVALUATIVE PROPERTIES OF THE SF-36 AND THE SF-6D INDEX

    May 1, 2010, 00:00

  • PHP66 EXCESS HOSPITAL COSTS ATTRIBUTABLE TO MEDICATION ERRORS IN HOSPITALIZED PATIENTS

    May 1, 2010, 00:00

  • ME2 THE EFFECT OF MEDICARE PART D PRESCRIPTION DRUG COVERAGE GAP ON MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PSY40 EXTENDED-RELEASE OXYMORPHONE IS ASSOCIATED WITH LOWER SUBJECTIVE MONETARY VALUE THAN CONTROLLED-RELEASE OXYCODONE IN NONDEPENDENT RECREATIONAL OPIOID USERS

    May 1, 2010, 00:00

  • PMH23 DEMOGRAPHIC AND CLINICAL PREDICTORS OF HIGH-DOSE PRESCRIPTION OF DULOXETINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

    May 1, 2010, 00:00

  • PND12 THE COST-EFFECTIVENESS OF XEOMIN IN CERVICAL DYSTONIA AND BLEPHAROSPASM IN SWEDEN

    May 1, 2010, 00:00

  • PRS16 ECONOMIC BURDEN OF EXACERBATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2010, 00:00

  • PHP24 THE PRESCRIPTION DRUG BURDEN FOR US ADULTS BETWEEN THE AGES OF 55 TO 64

    May 1, 2010, 00:00

  • PRS29 SMOKING AND WORKPLACE CONSEQUENCES- EVALUATION IN FRANCE

    May 1, 2010, 00:00

  • PHP102 ADVANCING THE EVIDENCE BASE FOR ORTHOTICS AND PROSTHETICS

    May 1, 2010, 00:00

  • PCN124 IDEAL VIAL SIZE FOR BORTEZOMIB- REAL WORLD DATA ON WASTE AND COST REDUCTION IN MULTIPLE MYELOMA (MM)

    May 1, 2010, 00:00

  • PCN96 A TRIAL-BASED ASSESSMENT OF THE COST-UTILITY OF BEVACIZUMAB AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2010, 00:00

  • PUK2 RETROSPECTIVE DATABASE EVALUATION OF PATIENT CHARACTERISTICS AND HEALTH CARE UTILIZATION OF MEMBERS WITH STAGE 3 CHRONIC KIDNEY DISEASE WITH ANEMIA

    May 1, 2010, 00:00

  • PND23 CONCORDANCE OF SELF-REPORT MEASURES OF DSM-IV-TR, ICD-IO, AND RDC INSOMNIA WITH STANDARDIZED CLINICAL ASSESSMENTS IN THE AMERICA INSOMNIA SURVEY (AIS)

    May 1, 2010, 00:00

  • PCN104 ESTIMATION AND COMPARISON OF EQ-5D HEALTH STATES UTILITY WEIGHTS FOR PNEUMOCCOCAL AND HUMAN PAPILLOMAVIRUS DISEASES IN ARGENTINA, CHILE AND THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PCV25 PERCUTANEOUS CORONARY INTERVENTION COMPARED WITH AORTOCORONARY BYPASS IN DIABETIC PATIENTS WITH MULTIVASCULAR CORONARY DISEASE

    May 1, 2010, 00:00

  • PCV144 DERIVING DOCTORS PRESCRIBING PATTERNS FROM CLAIMS DATA- AN APPLICATION TO ANTICOAGULANT USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

    May 1, 2010, 00:00

  • PMC10 RATIONALE AND DEVELOPMENT OF AN ONLINE DIRECTORY OF DATABASE PROFILES FOR PHARMACOEPIDEMIOLOGY, OUTCOMES, AND POPULATION RESEARCH

    May 1, 2010, 00:00

  • PND24 EVALUATING THE IMPACT OF RESTLESS LEGS SYNDROME (RLS) ON NEXT DAY FUNCTIONING

    May 1, 2010, 00:00

  • PCV71 COST-EFFECTIVENESS OF 123I-MIBG (ADREVIEW) IMAGING FOR PATIENT TREATMENT SELECTION IN THE PREVENTION OF SUDDEN CARDIAC DEATH

    May 1, 2010, 00:00

  • PDB29 COST/EFFECTIVENESS STUDY OF THIAZOLIDINEDIONES IN DIABETIC MEDICATION-A TAIWANESE EMPIRICAL STUDY

    May 1, 2010, 00:00

  • PMS32 ANTI-TUMOR NECROSIS FACTOR SWITCHING, DISCONTINUATION, AND PERSISTENCE IN MANAGED CARE PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PMH62 DISRUPTIONS IN ANTIPSYCHOTIC ADHERENCE ARE JOINTLY RELATED WITH REDUCED ADHERENCE FOR OTHER CHRONIC CONDITIONS

    May 1, 2010, 00:00

  • PCV123 DRUG UTILIZATION REVIEW OF DUAL ANTIPLATELET THERAPY AMONG TAIWANESE OLDER ADULTS

    May 1, 2010, 00:00

  • PDB78 RANDOMIZED CLINICAL TRIAL (RCT) DESIGN AND ANALYTIC ISSUES IMPACTING ASSUMED CLINICAL EFFECTS AND RESULTS OF COST-EFFECTIVENESS ANALYSES- ILLUSTRATION FROM A RECENT CANADIAN REPORT ON THE COST-EFFECTIVENESS OF BLOOD GLUCOSE TEST STRIP ...

    May 1, 2010, 00:00

  • PMH83 HEALTH CARE EXPENDITURES IN PEDIATRIC POPULATION WITH DEPRESSION IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN123 PREVALENCE AND CORRELATES OF HUMAN PAPILLOMAVIRUS VACCINATION IN ADOLESCENT GIRLS- RESULTS FROM NATIONAL SURVEY OF CHILDRENS HEALTH

    May 1, 2010, 00:00

  • PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS

    May 1, 2010, 00:00

  • PDB48 ASSESSING QUALITY OF LIFE IN SHORT STATURE YOUTH - THE QOLISSY PROJECT FOCUS GROUP AND COGNITIVE DEBRIEFING EXPERIENCE

    May 1, 2010, 00:00

  • PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

    May 1, 2010, 00:00

  • PIN35 ECONOMIC EVALUATION OF CEFTOBIPROLE FOR THE TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PDB13 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

    May 1, 2010, 00:00

  • PMC24 THE EFFECT OF FRAMING ON PREFERENCES FOR MAXIMIZING QALYS

    May 1, 2010, 00:00

  • PCN112 LITERATURE REVIEW AND PRODUCT LABEL CLAIM REVIEW FOR THE DEVELOPMENT OF A PATIENT-REPORTED OUTCOME RESEARCH STRATEGY FOR CANCER-RELATED ANEMIA

    May 1, 2010, 00:00

  • PMS16 ANALYSIS OF DIAGNOSES RELATED GROUP NUMBER 234-OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE-OPERATING ROOM PROCEDURES

    May 1, 2010, 00:00

  • PRS8 RISK OF SERIOUS ASTHMA EXACERBATION AND SPIROMETRY TEST IN CHILDREN

    May 1, 2010, 00:00

  • PMS41 MANAGEMENT OF KNEE OSTEOARTHRITIS- IMPACT ON PAIN ON A DAILY BASIS

    May 1, 2010, 00:00

  • PCN84 COST EFFECTIVENESS ANALYSIS OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR AGENTS FOR TREATMENT REFRACTORY METASTATIC COLORECTAL CANCER

    May 1, 2010, 00:00

  • PCV84 COST-EFFECTIVENESS OF ROSUVASTATIN 10 MG IN THE REDUCTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS AT RISK OF CARDIOVASCULAR DISEASE

    May 1, 2010, 00:00

  • PSY43 A COMPARISON OF PHYSICIAN-PRESCRIBED AND PATIENT/ CAREGIVER REPORTED DOSING OF RECOMBINANT FACTOR VII (RFVIIA)- HOME TREATMENT OF ACUTE BLEEDS IN THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)

    May 1, 2010, 00:00

  • PCN151 CLINICAL AND SOCIO-DEMOGRAPHIC DETERMINANTS OF PRIMARY PROPHYLACTIC G-CSF USE IN ELDERLY BREAST CANCER MEDICARE BENEFICIARIES RECEIVING CHEMOTHERAPY

    May 1, 2010, 00:00

  • PMS8 HIGH-COST MEDICATIONS IN 10 COUNTRIES- A CROSS-SECTIONAL COMPARATIVE STUDY

    May 1, 2010, 00:00

  • PMS19 REAL-WORLD USE OF DULOXETINE FOR LOW BACK PAIN AND CHRONIC LOW BACK PAIN- TREATMENT PATTERN, DIRECT AND INDIRECT COSTS

    May 1, 2010, 00:00

  • PCV82 ECONOMIC EVALUATION OF THE USE OF PERFLUOROCARBON EMULSION (PFC) VS. PERIOPERATIVE BLOOD TRANSFUSION IN CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS AT THE MEXICAN INSTITUTE OF SOCIAL SECURITY

    May 1, 2010, 00:00

  • PIN17 COST-EFFECTIVE ANALYSIS OF BEHAVIORAL INTERVENTIONS UTILIZING MEMS FOR ANTIRETROVIRAL MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PIN29 COST-EFFECTIVENESS OF THE SEQUENTIAL USE OF ANIDULAFUNGIN AND ORAL VORICONAZOLE IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NON-NEUTROPHENIC PATIENTS IN MEXICO

    May 1, 2010, 00:00

  • PUK26 THE NON-LINEAR RELATIONSHIP BETWEEN DOSING FREQUENCY AND BREAK-EVEN COSTS IN CAPITATED ESRD REIMBURSEMENT

    May 1, 2010, 00:00

  • PCN113 HEALTH RELATED QUALITY OF LIFE, FEAR OF RECURRENCE, IMPACT OF EVENTS, ILLNESS INTRUSIVENESS AND PSYHOLOGICAL DISTRESS IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

    May 1, 2010, 00:00

  • PCV149 QUALITY OF PHARMACEUTICAL CARE PROVIDED IN A CHRONIC DISEASE- GEOGRAPHIC VARIATION, PROCESS OF CARE MEASURES AND CLINICAL OUTCOMES

    May 1, 2010, 00:00

  • PGI36 USING PROPENSITY SCORE MATCHING TO ESTIMATE DIFFERENCES IN HEALTH CARE UTILIZATION BETWEEN PEOPLE WITH AND WITHOUT ULCERATIVE COLITIS

    May 1, 2010, 00:00

  • PMS4 CHARACTERIZING UNCERTAINTY IN EARLY-DEVELOPMENT BUDGETARY IMPACT MODELS- A CASE STUDY OF DENOSUMAB

    May 1, 2010, 00:00

  • PHP88 EVIDENCE USED DURING PHARMACEUTICAL TECHNOLOGY ASSESSMENT

    May 1, 2010, 00:00

  • PIN27 COST-EFFECTIVENESS ANALYSIS OF THE THERAPY FOR THE INVASIVE ASPERGILOSIS IN COLOMBIA

    May 1, 2010, 00:00

  • PMH77 THE RELIABILITY AND VALIDITY OF THE CLEAR THINKING SCALE (CTS) AMONG PATIENTS DIAGNOSED WITH SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PRS46 TEN YEAR TRENDS IN PRESCRIPTION OF CHRONIC OBSTRUCTIVE PULMONARY MEDICATION AMONG ADULTS FROM 1996 TO 2005

    May 1, 2010, 00:00

  • PGI21 ECONOMIC ANALYSIS OF ALVIMOPAN FOR PREVENTION AND MANAGEMENT OF POST-OPERATIVE ILEUS

    May 1, 2010, 00:00

  • HE2 HEALTH CARE COSTS OF METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK-FINDINGS FROM LINKED SEER-MEDICARE DATA

    May 1, 2010, 00:00

  • PND19 IMPACT OF MEDICATION ADHERENCE TO DISEASE-MODIFYING DRUGS ON SEVERE RELAPSE, AND DIRECT AND INDIRECT COSTS AMONG EMPLOYEES WITH MULTIPLE SCLEROSIS

    May 1, 2010, 00:00

  • PHP72 ASSESSING THE IMPACT AND VALUE OF HEALTH OUTCOMES PUBLICATIONS USING CITATION DATA FROM INDICES OF SCHOLARLY LITERATURE

    May 1, 2010, 00:00

  • PMS48 HYALURONIC ACID MANAGEMENT OF KNEE OSTEOARTHRITIS- IMPACT ON PAIN

    May 1, 2010, 00:00

  • PCN110 HOW MUCH DO PATIENTS WITH RENAL CELL CARCINOMA (RCC) VALUE PROGRESSION FREE SURVIVAL IN MEDICAL DECISION MAKING?-RESULTS FROM A BENEFIT-RISK CONJOINT STUDY

    May 1, 2010, 00:00

  • PCN47 COMPARISON OF HEALTH CARE RESOURCE UTILIZATION AND COSTS BETWEEN NILOTINIB AND DASATINIB AS SECOND LINE THERAPIES IN CHRONIC MYELOID LEUKEMIA (CML)

    May 1, 2010, 00:00

  • PCV96 IMPACT OF MEDICARE PART D ON ADHERENCE AND PERSISTENCE WITH STATIN MEDICATIONS FOR TEXAS DUAL-ELIGIBLE BENEFICIARIES

    May 1, 2010, 00:00

  • PCV105 UNDERSTANDING BARRIERS TO MEDICATION ADHERENCE FOR THE

    May 1, 2010, 00:00

  • PMH71 ISSUES IN THE USE OF THE HOSPITAL ANXIETY AND DEPRESSION SCALE IN AN ALCOHOL-DEPENDENT POPULATION

    May 1, 2010, 00:00

  • PMC25 PATIENT PREFERENCES FOR ADHERENCE TOOLS ACROSS 10 MEDICAL CONDITIONS

    May 1, 2010, 00:00

  • Abstracts Index

    May 1, 2010, 00:00

  • PHP28 EPISODES OF CARE AND INPATIENT MORTALITY FOLLOWING POISONINGS FROM OVER-THE-COUNTER MEDICATIONS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN60 COST-EFFECTIVENESS OF OXALIPLATIN AND IRINOTECAN BASED COMBINATION THERAPY COMPARED WITH 5FU/LV FOR THE TREATMENT OF US ELDERLY ADVANCED COLON CANCER PATIENTS

    May 1, 2010, 00:00

  • PMH86 AGE RELATED TREATMENT DIFFERENCES AMONG CHILDREN WITH BIPOLAR SPECTRUM DISORDERS

    May 1, 2010, 00:00

  • PUK5 DOES RACIAL VARIATION IN RISK FACTORS HAVE A ROLE TO PLAY IN THE INCIDENCE OF CHRONIC KIDNEY DISEASE IN THE US POPULATION

    May 1, 2010, 00:00

  • PCN102 EFFECTS OF VA ONCWATCH INTERVENTION ON COLORECTAL CANCER SCREENING ADHERENCE

    May 1, 2010, 00:00

  • PGI29 SELECTING CHRONIC CONSTIPATION (CC) CLINICAL TRIAL ENDPOINTS- INCORPORATING THE PATIENTS VOICE

    May 1, 2010, 00:00

  • PCV158 RARE EVENT BIAS IN RETROSPECTIVE ANALYSIS OF OUTCOMES MEASURES

    May 1, 2010, 00:00

  • PMH67 REFUSAL OF ANCILLARY SUPPORT SERVICES EARLY IN TREATMENT PREDICTS SIX MONTH OUTCOMES AMONG BUPRENORPHINE-MEDICATION ASSISTED TREATMENT PATIENTS

    May 1, 2010, 00:00

  • PGI28 UTILIZATION AND COST OF PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN THE MANAGEMENT OF CHRONIC HEPATITIS C VIRUS IN EUROPE

    May 1, 2010, 00:00

  • PCV31 DECLINING ISCHEMIC STROKE-RELATED INPATIENT UTILIZATION- RECENT TRENDS ANALYSIS OF UNITED STATES NATIONAL DATA 2000-2005

    May 1, 2010, 00:00

  • PMH12 THE COMPARATIVE EFFICACY OF INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN REDUCING RELAPSES IN ADULT SCHIZOPHRENIA PATIENTS- A SYSTEMATIC REVIEW AND MIXED TREATMENT COMPARISON ANALYSIS

    May 1, 2010, 00:00

  • PND20 PERCEIVED CAREGIVER BURDEN AND HEALTH RELATED QUALITY OF LIFE IN ALZHEIMERS CAREGIVERS

    May 1, 2010, 00:00

  • PCV44 BUDGET IMPACT OF BIVALIRUDIN IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) IN ITALIAN HOSPITALS

    May 1, 2010, 00:00

  • PCN14 SYSTEMATIC REVIEW OF EFFICACY OUTCOMES REPORTED IN RANDOMISED CONTROLLED TRIALS OF FIRST-LINE (1L) THERAPIES FOR METASTATIC BREAST CANCER (MBC)

    May 1, 2010, 00:00

  • PSY34 OBESITY AND HEALTH CARE COSTS AND UTILIZATION IN THE VETERAN AFFAIRS POPULATION

    May 1, 2010, 00:00

  • PCN134 THE ECONOMIC IMPACT OF CONTOUR VERSUS HAND SEWN SUTURE AND OTHER MECHANICAL STAPLES IN LOW ANTERIOR RESECTIONS IN COLON RECTAL CANCER SURGERY- INTERIM RESULTS USING REAL WORLD DATA FROM PREMIERS HOSPITAL DATABASE

    May 1, 2010, 00:00

  • PGI9 A BUDGET IMPACT MODEL TO EVALUATE MEDICATION PERSISTENCE AND ASSOCIATED HEALTH CARE COSTS

    May 1, 2010, 00:00

  • PRS30 HEALTH CARE RESOURCE USE AND TIME TO DIAGNOSIS ATTRIBUTABLE TO MANAGING COW MILK ALLERGY IN THE USA- CURRENT ESTIMATES AND PREDICTED EFFECTS OF LEGISLATION THAT REQUIRES HEALTH CARE COVERAGE FOR AMINO ACID FORMULAS

    May 1, 2010, 00:00

  • PCN97 ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CETUXIMAB TREATMENT DECISION MODEL- CHEMOTHERAPYCETUXIMAB VS. CETUXIMAB TREAT-TO-RASH STRATEGY VS. CHEMOTHERAPY ONLY IN FIRST-LINE TREATMENT OF STAGE IIIB/IV NSCLC

    May 1, 2010, 00:00

  • PIH7 PREDICTORS OF NON-MEDICAL USE OF PRESCRIPTION DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES

    May 1, 2010, 00:00

  • PND25 REFINING THE MEASUREMENT OF MOTOR AND NON-MOTOR SYMPTOMS IN PARKINSONS DISEASE PATIENTS WITH FLUCTUATING SYMPTOMS

    May 1, 2010, 00:00

  • PCASE1 UTILIZING EVIDENCE FROM DIFFERENT LEVELS IN THE REIMBURSEMENT PROCESS OF NEW MEDICAL TECHNOLOGIES-ADVANCED RENAL CELL CARCINOMA FIRST LINE THERAPY IN POLAND 2008-2009

    May 1, 2010, 00:00

  • PCN129 RACIAL DISPARITIES ASSOCIATED WITH TREATMENT AND SURVIVAL IN ELDERLY PATIENTS WITH EARLY STAGE OPERABLE BREAST CANCER

    May 1, 2010, 00:00

  • PDB34 A COST-MINIMIZATION ANALYSIS FOR TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETERMIR IN A BASAL SUPPORTED ORAL THERAPY IN CHINA

    May 1, 2010, 00:00

  • PCN94 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS

    May 1, 2010, 00:00

  • PR3 NATIONAL CULTURE AND EQ-5D VALUE SETS

    May 1, 2010, 00:00

  • PIN30 CLINICAL AND ECONOMIC IMPACT OF I 3-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN SINGAPORE AND HONG KONG

    May 1, 2010, 00:00

  • PHP65 USEFFULNESS OF COST PER DEFINED DAILY DOSE (DDD) TO IDENTIFY PROBLEMATIC DRUGS IN MEDIUM- AND HIGH-LEVEL COMPLEXITY HOSPITALS FROM COLOMBIA

    May 1, 2010, 00:00

  • PMS40 CREATION OF A SHORT VERSION OF THE VALUED LIFE ACTIVITIES QUESTIONNAIRE (S-VLA)

    May 1, 2010, 00:00

  • PCV30 TARGETING AFRICAN AMERICANS WITH CONGESTIVE HEART FAILURE- THE CASE OF BIDIL

    May 1, 2010, 00:00

  • PMH11 DISCRETE EVENT SIMULATION MODEL IN MAJOR DEPRESSIVE DISORDER- LIFE-TIME HEALTH OUTCOMES OF ADJUNCTIVE ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PCASE4 HOW TO IMPLEMENT NATIONAL ESSENTIAL MEDICINE LIST IN SHANGHAI- PROS CONS

    May 1, 2010, 00:00

  • PSY37 COMPARING THE TIME TRADEOFF (TTO), THE VISUAL ANALOGUE SCALE (VAS) AND THE EQ-5D VALUE-SETS IN PATIENTS TREATED WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) OR POST-HERPETIC NEURALGIA (PHN)

    May 1, 2010, 00:00

  • PCV146 STATIN USE BEFORE AND AFTER CABG PROCEDURE

    May 1, 2010, 00:00

  • PMS2 ESTIMATING HEALTH-RELATED UTILITY FROM CLINICALLY ASSESSED DISEASE SEVERITY IN ANKYLOSING SPONDYLITIS

    May 1, 2010, 00:00

  • PCV7 INCIDENCE AND OUTCOMES OF POTENTIAL DRUG-DRUG INTERACTIONS BETWEEN ACE/ARB AND POTASIUM SPARING DIURETICS

    May 1, 2010, 00:00

  • PMC28 INITIAL EXPERIENCE WITH THE PROMIS MEASUREMENT SYSTEM IN CLINICAL POPULATIONS

    May 1, 2010, 00:00

  • PHP8 BENEFICIARY CHOICE IN MEDICARE PART D

    May 1, 2010, 00:00

  • PMH35 COMPARATIVE EFFECTIVENESS OF LONG-ACTING RISPERIDONE- A REPORT OF RESOURCE UTILISATION AND COSTS IN A 12 MONTH MIRROR-IMAGE ANALYSIS

    May 1, 2010, 00:00

  • PMS24 COST-EFFECTIVENESS COMPARATIVE ANALYSIS OF BISPHOSPHONATES FOR THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS

    May 1, 2010, 00:00

  • PCN140 INFLUENCE OF HEALTH TECHNOLOGY ASSESSMENTS ON UTILIZATION OF BEVACIZUMAB IN EUROPE

    May 1, 2010, 00:00

  • PND39 AGREEMENT BETWEEN MULTIPLE SCLEROSIS-RELATED VARIABLES IN MEDICAL CHARTS AND CLAIMS DATA

    May 1, 2010, 00:00

  • PRS45 INTEGRATED EDUCATIONAL PROJECT WITH INDIVIDUAL FEEDBACK FROM CLAIMS DATA LEADS TO IMPROVED ANTIBIOTIC PRESCRIPTION AND RESISTANCE DECREASE

    May 1, 2010, 00:00

  • PHP39 SENSITIVITY OF MEDICATION USE AND OUTCOMES TO FORMULARY CONTROLS IN THE ELDERLY- A REVIEW OF THE LITERATURE

    May 1, 2010, 00:00

  • PMH78 ANALYSIS OF ADOLESCENT PATIENTS WITH NON-DEPRESSIVE NEUROSES IN COMPARISON TO THE GENERAL INPATIENT GROUP

    May 1, 2010, 00:00

  • PIN19 A PHARMACOECONOMICS ANALYSIS OF ERTAPENEN VS SEVERAL ANTIBIOTICS USED FOR THE TREATMENT OF COMMUNITY-ACQUIRED INTRA-ABDOMINAL INFECTIONS AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2010, 00:00

  • PUK16 COST-EFFECTIVENESS ANALYSIS IN TREATING OVERACTIVE BLADDER WITH URGE INCONTINENCE IN WOMEN- A COMPARISON BETWEEN OXYBUTYNIN AND TOLTERODINE WITH EXPLORATORY ANALYSIS OF FESOTERODINE

    May 1, 2010, 00:00

  • PUK22 REJECTION EPISODES REQUIRING HOSPITALIZATION AFTER KIDNEY TRANSPLANT IN BRAZIL- A RETROSPECTIVE DATABASE STUDY OF THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2010, 00:00

  • PHP115 AN ECONOMIC EVALUATION OF FIBRIN SEALANTS USED DURING INCISIONAL HERNIA WITH DERMOLIPECTOMY PROCEDURES IN SPAIN

    May 1, 2010, 00:00

  • PMS49 TRENDS IN THE PRESCRIBING OF CONVENTIONAL ANTIRHEUMATIC THERAPY AMONG CANADIANS WITH RHEUMATOID ARTHRITIS- A RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PIN32 COST-EFFECTIVENESS OF 2009 PANDEMIC INFLUENZA A(H I N I) VACCINATION IN THE UNITED STATES

    May 1, 2010, 00:00

  • PUK1 INCIDENCE AND COST OF ADVERSE EVENTS (AES) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) TREATED WITH ANGIOGENESIS INHIBITORS (AIS)

    May 1, 2010, 00:00

  • PDB74 TREATMENT OF TYPE 2 DIABETES VS. CLINICAL GUIDELINES

    May 1, 2010, 00:00

  • PUK10 IMPROVED RESOURCE UTILIZATION OUTCOMES ASSOCIATED WITH PREDIALYSIS USE OF PARICALCITOL FOR SECONDARY HYPERPARATHYROIDISM (SHPT)

    May 1, 2010, 00:00

  • PDB43 ADHERENCE AND PERSISTENCE AMONG TYPE II DIABETIC PATIENTS STARTING MONOTHERAPY ON ORAL HYPOGLYCEMIC AGENTS

    May 1, 2010, 00:00

  • PMC37 PATIENT REPORTED OUTCOME RECALL PERIODS IN LIGHT OF THE FINAL FDA GUIDANCE

    May 1, 2010, 00:00

  • PCV48 COMMUNITY-BASED CARE FOR THE SPECIALIZED MANAGEMENT OF HEART FAILURE- A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS

    May 1, 2010, 00:00

  • PMH1 SIDE EFFECTS ASSOCIATED WITH PRESCRIPTION OF METHYLPHENIDATE IN TAIAWN

    May 1, 2010, 00:00

  • PCV76 SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF SELECTED CARDIAC IMAGING TECHNOLOGIES IN THE DIAGNOSIS OF CORONARY ARTERY DISEASE

    May 1, 2010, 00:00

  • PRS12 PULMONARY REHABILITATION- A BUDGET IMPACT MODEL TO EVALUATE HOW POLICY CHANGES WILL IMPACT REIMBURSEMENT FROM A MANAGED CARE PERSPECTIVE

    May 1, 2010, 00:00

  • PRS7 TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2010, 00:00

  • PMH43 DECLINE IN THE RATE AND COST OF PSYCHIATRIC HOSPITALIZATION FOLLOWING INITIATION OF DEPOT ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PDB63 COMPARATIVE RESULTS ON EFFECTS OF TYPES OF INSURANCE AND PAYMENT PLANS ON PHYSICIANS COST AWARENESS DURING THE PHYSICIAN VISIT USING THE NAMCS SURVEY IN 1996 AND 2005

    May 1, 2010, 00:00

  • PHP75 A FRAMEWORK TO ASSIST PHARMACEUTICAL COMMERCIALIZATION TEAMS IN EFFICIENTLY ALLOCATING RESOURCES TO GENERATE EVIDENCE OF PRODUCT VALUE TO SUPPORT GLOBAL MARKET ACCESS ACROSS DIVERSE PAYER ENVIRONMENTS

    May 1, 2010, 00:00

  • PCV52 COMPLIANCE AND HEALTH CARE UTILIZATION AMONG PATIENTS WITH HYPERTENSION TREATED WITH SINGLE PILL VS. FREE COMBINATION ANTIHYPERTENSIVE THERAPY- U.S. NATIONAL AND STATE LEVEL RESULTS FROM A CLAIMS DATABASE ANALYSIS

    May 1, 2010, 00:00

  • HT3 MULTICRITERIA DECISION ANALYSIS (MCDA) FOR DRUG COVERAGE DECISION BY A PUBLIC HEALTH PLAN- CASE STUDY OF TRAMADOL FOR CHRONIC NON-CANCER PAIN (CNCP) IN CANADA

    May 1, 2010, 00:00

  • PCN78 COST-EFFECTIVENESS MODELLING OF EPOETIN ALFA AND DARBEPOETIN ALFA IN THE TREATMENT OF CHEMOTHERAPYRELATED ANAEMIA IN SWEDEN

    May 1, 2010, 00:00

  • PHP76 DRUG POLICY IN SLOVAKIA- IMPACT OF PRICING AND REIMBURSEMENT REFORMS

    May 1, 2010, 00:00

  • PCN67 COST-UTILITY OF KRAS MUTATION TESTING PRIOR TO TREATMENT OF METASTATIC COLORECTAL CANCER WITH CETUXIMAB MONOTHERAPY

    May 1, 2010, 00:00

  • PGI37 FACTORS ASSOCIATED WITH THE USE OF ENTERAL AND PARENTERAL PROTON PUMP INHIBITOR USE IN CRITICALLY ILL PATIENTS

    May 1, 2010, 00:00

  • PRS37 DRUG UTILIZATION PATTERNS FOR PEDIATRIC ASTHMA IN AMBULATORY CARE SETTINGS

    May 1, 2010, 00:00

  • PMC38 DETERMINING MISSING DATA RULES FOR PROS- ALPHA-IF-ITEM-DELETED

    May 1, 2010, 00:00

  • PCN48 NON-ADHERENCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IS ASSOCIATED WITH SHORT- AND LONG-TERM NEGATIVE IMPACTS ON HEALTH CARE RESOURCE UTILIZATION AND COSTS

    May 1, 2010, 00:00

  • CM2 EFFECTS OF NONADHERENCE WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKERS ON HOSPITALIZATION AND MORTALITY AMONG PATIENTS WITH DIABETES

    May 1, 2010, 00:00

  • PHP59 PHARMACY BENEFIT INTEGRATION AND ADHERENCE TO EVIDENCE-BASED MEDICINE IN A COMMERCIALLY-INSURED POPULATION

    May 1, 2010, 00:00

  • PSY19 MULTIPLE MYELOMA- PATIENT OUT-OF-POCKET COSTS AND HEALTH-CARE UTILIZATION

    May 1, 2010, 00:00

  • PDB2 THE IMPACT OF ORAL ANTIDIABETICS ON WEIGHT IN THE ELDERLY WITH TYPE 2 DIABETES MELLITUS IN THE AMBULATORY SETTING

    May 1, 2010, 00:00

  • PIN5 A BUDGET IMPACT ANALYSIS OF THREE PRESURGICAL SKIN ANTISEPSIS PROTOCOLS

    May 1, 2010, 00:00

  • PUK28 ASSESSMENT OF RECENT ERYTHROPOIESIS-STIMULATING AGENT GUIDELINES CHANGES ON DOSING PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS

    May 1, 2010, 00:00

  • PCN69 COST-EFFECTIVENESS OF LENOGRASTYM ON NEUTROPENIA DURATION IN CHILDREN RECEIVING CHEMOTHERAPY FOR LEUKEMIA

    May 1, 2010, 00:00

  • PCV130 EVALUATION ON THE DRUGS AND MEDICAL COST OF PATIENTS WITH HYPERTENSION IN CHINA

    May 1, 2010, 00:00

  • PHP106 THE HEALTH ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN THE COMMUNITY SETTING IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PMS14 CHARACTERIZING LOST PRODUCTIVITY AND DIRECT AND INDIRECT COSTS OF RHEUMATOID ARTHRITIS-A LARGE, SELF-INSURED EMPLOYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PMC40 INSTIGATING AND ENCOURAGING INDIVIDUAL HEALTH BEHAVIORS THROUGH TECHNOLOGY- A TRANSTHEORETICAL PROPOSITION

    May 1, 2010, 00:00

  • PHP13 MEDICARE PART D AND ITS IMPACT ON PRESCRIPTION DRUG USE

    May 1, 2010, 00:00

  • PND11 HEALTH ECONOMIC IMPACT OF EARLY TREATMENT OF MULTIPLE SCLEROSIS WITH DISEASE MODIFYING THERAPY

    May 1, 2010, 00:00

  • PHP45 COMPARISONS OF EMPLOYEE WORKERS COMPENSATION COSTS AND ABSENCE DAYS USING A NATIONAL DATABASE

    May 1, 2010, 00:00

  • CE4 A PRELIMINARY COST-EFFECTIVENESS ANALYSIS OF TARGETED VACCINATION POLICIES TO MITIGATE THE IMPACT OF THE H1N1 PANDEMIC IN THE US

    May 1, 2010, 00:00

  • PCN72 ECONOMIC EVALUATION OF SUNITINIB VS. INTERFERON-A AND BEVACIZUMAB INTERFERON-A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (CCRM) - BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE

    May 1, 2010, 00:00

  • PUK9 SEVEN YEAR TRENDS OF PHARMACY BENEFIT ERYTHROPOIESIS-STIMULATING AGENT UTILIZATION AND COST CONSIDERATIONS OF CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS

    May 1, 2010, 00:00

  • PCN79 REVIEW OF COST-EFFECTIVENESS STUDIES ON AROMATASE INHIBITORS FOR THE TREATMENT OF EARLY-STAGE BREAST CANCER

    May 1, 2010, 00:00

  • TR4 PUBLIC HEALTH AND ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN AN INFLUENZA PANDEMIC IN SINGAPORE AND HONG KONG

    May 1, 2010, 00:00

  • PCV34 ATRIALL FIBRILLATION EPIDEMIOLOGY AND MANAGEMENT IN PRIMARY CARE

    May 1, 2010, 00:00

  • PGI32 CORRESPONDENCE OF MULTIPLE HEALTH OUTCOMES MEASURES IN RESPONSIVENESS TO MMX MESALAMINE TREATMENT FOR PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2010, 00:00

  • PCV141 UTILIZATIONAND EXPENDITURE TRENDS FOR BOTH ANGIOTENSINCONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN THE MEDICAID PROGRAM

    May 1, 2010, 00:00

  • PCV62 ONE-YEAR CLINICAL AND ECONOMIC OUTCOMES EVALUATION OF PTCA WITH STENTING

    May 1, 2010, 00:00

  • PHP95 ANALYSIS OF 'BRIDGING THERAPY' IN ORTHOPEDIC PATIENTS IN A U.S. HEALTH PLAN

    May 1, 2010, 00:00

  • PMC31 THE ROLE OF THE PATIENT VOICE IN HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2010, 00:00

  • PHP26 THE IMPACT OF MISUSE OF ANTIBIOTIC THERAPIES ON INPATIENT COSTS

    May 1, 2010, 00:00

  • PIH11 THE BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) ON PATIENTS HOSPITALIZED WITH A PRIMARY DIAGNOSIS OF OPPOSITIONAL DEFIANT DISORDER (ODD)

    May 1, 2010, 00:00

  • PMH75 EFFECT OF EQUIVALENT AND NON-EQUIVALENT SUBSTITUTION OF PRESCRIBED DRUGS FOR DEPRESSION AND ANXIETY DISORDERS ON PATIENTS TREATMENT ADHERENCE AND PERCEPTION

    May 1, 2010, 00:00

  • PCV97 ANALYSIS ON THE EFFECTS OF MEDICARE PART D COVERAGE GAP ON STATIN MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PDB31 REDUCED LONG-TERM COSTS AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS INITIATED ON RAPID-ACTING INSULIN ASPART COMPARED WITH HUMAN INSULIN

    May 1, 2010, 00:00

  • RM3 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATIPSYCHOTIC AGENTS- A PROPENSITY-MATCHED RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PMH91 EXAMINATION OF DOCTORS PRACTICE AND PRESCRIBING PATTERNS TOWARD SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SERTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS

    May 1, 2010, 00:00

  • PHP92 HEALTH CARE PROFESSIONAL STUDENTS KNOWLEDGE OF DRUG-DRUG INTERACTIONS- A PRETEST POSTTEST STUDY

    May 1, 2010, 00:00

  • PMC47 STATISTICAL METHODS NEEDED IN HEALTH ECONOMICS

    May 1, 2010, 00:00

  • PCN23 OVERALL SURVIVAL AND GAP IN DOCETAXEL TREATMENT CONTINUATION IN PATIENTS WITH METASTATIC PROSTATE CANCER - RESULTS FROM A US ONCOLOGY NETWORK

    May 1, 2010, 00:00

  • PSY26 COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN BRAZIL

    May 1, 2010, 00:00

  • PSY36 CORRELATES OF ADHERENCE TO IMMUNOSUPPRESSANT MEDICATIONS IN COMMUNITY DWELLING SOLID ORGAN TRANSPLANT RECIPIENTS

    May 1, 2010, 00:00

  • PCV64 IMPACT OF WORSENING RENAL FUNCTION ON HEALTH CARE UTILIZATION OBSERVED AMONG HOSPITALIZED HEART FAILURE PATIENTS

    May 1, 2010, 00:00

  • PCV14 COMPARATIVE EFFECTIVENESS ANALYSIS IDENTIFIES A SUPERIOR POINT OF CARE DEVICE FOR ASSESSING THE INTERNATIONAL NORMALIZED RATIO

    May 1, 2010, 00:00

  • PSY13 COMPARISON OF TOTAL HEALTH CARE EXPENDITURES AND ABSENTEEISM FOR INFLAMMATORY BOWEL DISEASE FROM AN EMPLOYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PMH74 INTENSIVE COGNITIVE INTERVIEWING WITH PATIENTS DIAGNOSED WITH SCHIZOPHRENIA AND THE REFINEMENT OF THE CLEAR THINKING SCALE (CTS)

    May 1, 2010, 00:00

  • PMS22 THE COST-EFFECTIVENESS OF PREGABALIN (LYRICA) IN THE TREATMENT OF SEVERE FIBROMYALGIA IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP40 IMPORTANCE OF CONSIDERING THE TREATMENT COMPLEMENTARITY OF MEDICINES IN DESIGNING PHARMACEUTICAL BENEFITS

    May 1, 2010, 00:00

  • PMS36 INJECTION SITE REACTION QUESTIONNAIRE- AN ADEQUATE TOOL FOR MEASURING INJECTION SITE REACTIONS?

    May 1, 2010, 00:00

  • PCN66 OPEN VERSUS LAPAROSCOPIC PROCEDURES FOR COLECTOMY SURGERY FOR PATIENTS WITH COLON RECTAL CANCER- A COST EFFECTIVENESS ANALYSIS, UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    May 1, 2010, 00:00

  • PDB52 ATTEMPTED WEIGHT LOSS OR REGULAR EXERCISE- IMPACT ON QUALITY OF LIFE AMONG ADULTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS

    May 1, 2010, 00:00

  • PCV133 THE COST-EFFECTIVENESS OF GENOTYPING CYP2C19 TO GUIDE ANTIPLATELET THERAPY SELECTION

    May 1, 2010, 00:00

  • PCN4 INSULINS AND RISK OF CANCER AMONG TYPE 2 DIABETICS- A SYSTEMATIC REVIEW

    May 1, 2010, 00:00

  • PSY54 NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) PRESCRIPTION USE FOR MUSCULOSKELETAL PAIN AT FOUR PRIMARY CARE CENTERS IN SWEDEN

    May 1, 2010, 00:00

  • PHP82 PHARMACISTS PERSPECTIVE ON RECENT LABELING CHANGES REQUIRED BY FDA FOR OVER-THE-COUNTER INTERNAL ANALGESIC, ANTIPYRETIC AND ANTIRHEUMATIC DRUGS

    May 1, 2010, 00:00

  • PMH25 ASSESSMENT OF HOSPITALIZATION RISK AMONG PATIENTS WITH BIPOLAR I DISORDER TREATED WITH ANTIPSYCHOTIC THERAPY IN A COMMERCIALLY INSURED POPULATION

    May 1, 2010, 00:00

  • PCV116 HEALTH-RELATED QUALITY OF LIFE OF DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

    May 1, 2010, 00:00

  • PMS62 DIFFERENCES IN DEMOGRAPHICS AND PRE-INDEX HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TAKING ANTI-TNF BIOLOGICS DURING THE FIRST YEAR OF PERSISTENT THERAPY

    May 1, 2010, 00:00

  • PRS25 ALBUTEROL AND LEVALBUTEROL USE AND SPENDING IN MEDICARE BENEFICIARIES WITH COPD

    May 1, 2010, 00:00

  • PMH22 THE IMPACT OF OUTPATIENT MENTAL HEALTH SERVICES ON RE-ARRESTS AMONG GROUPS OF INDIVIDUALS WITH A SERIOUS MENTAL ILLNESS IN TWO URBAN COUNTIES, ONE IN FLORIDA AND ONE IN TEXAS

    May 1, 2010, 00:00

  • PHP113 A NOVEL APPROACH FOR ESTIMATING RESOURCE UTILIZATION IN PATIENTS WITH SUSPECTED IMMUNE-MEDIATED COAGULOPATHY ASSOCIATED WITH EXPOSURE TO TOPICAL BOVINE THROMBIN

    May 1, 2010, 00:00

  • PIH9 TRENDS IN IUD INSERTIONS AND RELATED MEDICAL EXPENDITURE IN THE UNITED STATES- THE POPULATION WITH EMPLOYERSPONSORED INSURANCE

    May 1, 2010, 00:00

  • PCN160 PATIENT-REPORTED OUTCOMES SUPPORTING ONCOLOGY PRODUCT LABELING CLAIMS- TRENDS AND CHALLENGES

    May 1, 2010, 00:00

  • PCV112 RESPONSIVENESS OF AF6, A NEW, SHORT, VALIDATED, AF-SPECIFIC QUESTIONNAIRE-SYMPTOMTIC BENEFIT OF DC CARDIOVERSION

    May 1, 2010, 00:00

  • PHP49 POTENTIAL SAVINGS FROM BROAD USE OF 4 GENERIC DRUGS- 2007 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2010, 00:00

  • PIN45 POLYMORBIDITY, THERAPY AND COSTS OF AMBULATORY CARE FOR HEPATITIS C PATIENTS IN GERMANY

    May 1, 2010, 00:00

  • PSY50 DISPARITY IN THE MANAGEMENT OF OBESITY IN AMBULATORY SETTING- A NAMCS 2006-07 ANALYSIS

    May 1, 2010, 00:00

  • PDB15 ECONOMIC OUTCOMES OF THREE INSULIN THERAPY PROTOCOLS IMPLEMENTED IN A SURGICAL INTENSIVE CARE UNIT

    May 1, 2010, 00:00

  • PHP32 ASSOCIATION OF PAYER STATUS WITH LENGTH OF STAY IN PATIENTS HOSPITALIZED FOR INJURY IN 2006 NHAMCS-ED DATA

    May 1, 2010, 00:00

  • PHP34 RACIAL AND ETHNIC DISPARITIES IN THE PHARMACEUTICAL COST UNDER MEDICARE PART D

    May 1, 2010, 00:00

  • PMS59 A RETROSPECTIVE STUDY OF INCIDENCE, PREVALENCE, TREATMENT PATTERNS AND COST OF RHEUMATOID ARTHRITISS IN TAIWAN USING THE NATIONAL HEALTH INSURANCE DATA

    May 1, 2010, 00:00

  • PSY24 COST-EFFECTIVENESS OF HAEMATE P PROPHYLACTIC TREATMENT FOR BLEEDING EPISODES IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE

    May 1, 2010, 00:00

  • PCV4 COMPARISON OF MORTALITY, RE-HOSPITALIZATION AND BLEEDING RATES OF MEDICARE PATIENTS WHO UNDERWENT KNEE REPLACEMENT SURGERY AND SUFFERED VENOUS THROMBOEMBOLISM VERSUS NO VENOUS THROMBOEMBOLISM

    May 1, 2010, 00:00

  • PCASE3 IMPACT OF DRUG POLICY ON IMPROVING ACCESS TO MEDICINES IN DELHI

    May 1, 2010, 00:00

  • PGI17 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PMH57 PSYCHIATRIC-RELATED HEALTH CARE COSTS AND RISK OF HOSPITALIZATION AMONG MEDICAID PATIENTS WITH TYPE I BIPOLAR DISORDER WHO RELAPSE FREQUENTLY

    May 1, 2010, 00:00

  • PSY57 MAINTENANCE INFLIXIMAB DOSING AND ADMINISTRATION PATTERNS IN PATIENTS WITH CROHNS DISEASE

    May 1, 2010, 00:00

  • PCN111 PRO LABELLING CLAIMS IN ANTINEOPLASTIC AGENTS

    May 1, 2010, 00:00

  • PND7 THE IMPACT OF SPECIALTY PHARMACY PARTICIPATION ON HEALTH CARE COSTS IN A MULTIPLE SCLEROSIS POPULATION USING BIOLOGIC DMD THERAPY

    May 1, 2010, 00:00

  • PDB26 MODELLING COST EFFECTIVENESS OF BEHAVIOUR MODIFICATION PROGRAMMES AND EFFECTS ON MEDICATION- CASE STUDY OF EDUCATION PROGRAMMES IN DIABETES

    May 1, 2010, 00:00

  • PIH24 EVALUATION OF THE AMERICAN (U.S.A.) VERSION OF THE ENDOMETRIOSIS HEALTH PROFILE (EHP-30)

    May 1, 2010, 00:00

  • PCV54 THE INCIDENCE AND COST OF SURGICAL SITE INFECTION (SSI) FOR COMMON CARDIOTHORACIC SURGICAL PROCEDURES IN THE USA- A STUDY USING THE PREMIER PERSPECTIVE DATABASE (PPD)

    May 1, 2010, 00:00

  • PSS14 VALIDATION OF THE EYELASH SATISFACTION FOLLOW-UP QUESTIONNAIRE FOR FOLLOW-UP SELF-ASSESSMENT OF EYELASH SATISFACTION

    May 1, 2010, 00:00

  • PM4 TRANSLATIONAL AND POLICY RESEARCH IN PERSONALIZED MEDICINE FOR CANCER

    May 1, 2010, 00:00

  • PMS57 EVIDENCE APPRAISAL FOR THE TREATMENT OF FIBROMYALGIA- COMPENDIA, GUIDELINES, AND A REVIEW OF CLINICAL TRIALS

    May 1, 2010, 00:00

  • PCN57 COSTS ASSOCIATED TO THE TREATMENT OF DIFFERENT STAGES OF MEXICAN PATIENTS WITH COLORECTAL CANCER

    May 1, 2010, 00:00

  • PMS64 PROJECTION OF SURGICAL LOADS OF HIP AND KNEE ARTHROPLASTY IN GERMANY

    May 1, 2010, 00:00

  • PCV110 DISCRIMINATORY POWER OF THE KCCQ IN ESTIMATING HEALTH UTILITIES IN HEART FAILURE PATIENTS

    May 1, 2010, 00:00

  • PGI19 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCN93 COST-EFFECTIVENESS ANALYSIS OF BENDAMUSTINE COMPARED TO ALEMTUZUMAB AND CHLORAMBUCIL FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN A TREATMENT-NAIVE POPULATION

    May 1, 2010, 00:00

  • PMC20 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE EQ-5D VISUAL ANALOGUE SCALE (VAS)

    May 1, 2010, 00:00

  • PMH90 WEB-SURVEYS- REAL WORLD EVIDENCE GATHERING AND MINIMIZING UNCERTAINTY IN ECONOMIC MODELS

    May 1, 2010, 00:00

  • PCN145 A COMPARISON OF PHYSICIAN AND PATIENT DECISION MAKING FOR FIRST VERSUS SECOND OPINIONS AMONG MEN WITH LOCAL STAGE PROSTATE CANCER

    May 1, 2010, 00:00

  • PCN58 BEVACIZUMAB FOR THE TREATMENT OF METASTATIC BREAST CANCER- A COST-EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PMH20 USE OF A LINKED HOSPITAL ADMISSIONS AND HEALTH CARE CLAIMS DATABASE IN PHARMACEUTICAL OUTCOMES RESEARCH- RESULTS OF A FEASIBILITY STUDY EXAMINING TREATMENT OF SCHIZOPHRENIA WITH ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PHP27 TRENDS IN EMERGENCY DEPARTMENT VISITS DUE TO OPIOID ABUSE IN THE UNITED STATES, 1996-2007

    May 1, 2010, 00:00

  • PCV32 RISK FACTORS ASSOCIATED WITH PREVALENCE OF HYPERTENSION- EVIDENCE FROM THE 2007 KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (K-NHANES)

    May 1, 2010, 00:00

  • PCV94 CONCORDANCE AMONG THREE SELF-REPORTED MEASURES OF MEDICATION ADHERENCE AND COUNT OF TABLETS RECORDS IN COLOMBIAN HYPERTENSIVE PATIENTS

    May 1, 2010, 00:00

  • PSS12 MODELING THE COST-EFFECTIVENESS OF USTEKINUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN US

    May 1, 2010, 00:00

  • PCV117 QUALITY OF LIFE OF PATIENTS WITH HYPERTENSION USING THE 2007 NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) OF KOREA

    May 1, 2010, 00:00

  • PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKINS LYMPHOMA PATIENTS

    May 1, 2010, 00:00

  • PIH8 DOES TRIAL PARTICIPATION IMPACT ON THE PSYCHOMETRIC PROPERTIES OF SELF-REPORT DEPRESSION IN POSTNATAL WOMEN?

    May 1, 2010, 00:00

  • PCV119 MANAGEMENT OF ACUTE ISCHEMIC STROKE IN THE USA

    May 1, 2010, 00:00

  • PCV74 COST-EFFECTIVENESS OF STATIN THERAPY FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS PREDICTED BY THE REYNOLDS RISK SCORE IN HEALTHY MEN AND WOMEN AGED 40 TO 80 YEARS OF AGE

    May 1, 2010, 00:00

  • PSY33 OPIOID USE AND COSTS IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY TREATED WITH PREGABALIN OR STAN DARD-OF-CARE

    May 1, 2010, 00:00

  • SB2 COMPARING BINARY PROPENSITY SCORE ANALYSIS WITH MULTIPLE PROPENSITY SCORE APPROACH AMONG PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2010, 00:00

  • PDB62 EFFECTS OF HEALTH INSURANCE PLAN TYPE ON HEALTH CARE RESOURCE UTILIZATION IN ADULT WORKING AGE PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2010, 00:00

  • PCV50 COST OF VTE EVENTS FOR MEDICARE PATIENTS UNDERGOING MAJOR ORTHOPAEDIC SURGERIES ACCORDING TO DISCHARGE STATUS

    May 1, 2010, 00:00

  • PND8 APPROACH TO MATCHING ALZHEIMERS DISEASE PATIENTS AND THEIR SPOUSES TO ASSESS CAREGIVER BURDEN IN AN ADMINISTRATIVE CLAIMS DATABASE

    May 1, 2010, 00:00

  • PHP78 UNDERSTANDING DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE COMMON DRUG REVIEW (CDR)

    May 1, 2010, 00:00

  • PCV152 TREATMENT PATTERNS, RESOURCE UTILIZATION AND COSTS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE US

    May 1, 2010, 00:00

  • PDB35 COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VS. METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE 2 DIABETES PATIENTS IN ARGENTINA

    May 1, 2010, 00:00

  • PIN47 FEASIBILITY STUDY OF A NOVEL METHOD TO QUANTIFY SURGICAL INTERVENTIONS IN PATIENTS WITH COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS (CSSSl) USING HOSPITAL ELECTRONIC HEALTH RECORD DATA

    May 1, 2010, 00:00

  • PMC43 EIGHT KEY EVIDENCES FOR CONTENT VALIDITY OF PATIENT REPORTED OUTCOME (PRO) INSTRUMENTS

    May 1, 2010, 00:00

  • PMS70 CONCORDANCE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG PRESCRIPTIONS WITH RECENT CLINICAL PRACTICE GUIDELINES IN QUEBEC, CANADA

    May 1, 2010, 00:00

  • PCV33 WHAT IS THE IMPACT OF SWITCHING FROM AN ACE INHIBITOR TO AN ANGIOTENSIN RECEPTOR BLOCKER ON BLOOD PRESSURE AND CARDIOVASCULAR EVENTS?

    May 1, 2010, 00:00

  • PCN17 CASTRATION-RESISTANT PROSTATE CANCER (CRPC)- A UK EPIDEMIOLOGY STUDY

    May 1, 2010, 00:00

  • PSY42 ASSOCIATION BETWEEN SELF-REPORTED NEUROPATHIC PAIN SEVERITY AND THE EQ-5D IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) OR POST-HERPETIC NEURALGIA (PHN)

    May 1, 2010, 00:00

  • PSS16 SUSTAINED IMPROVEMENT IN SKIN DISEASE-SPECIFIC QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS RECEIVING USTEKINUMAB MAINTENANCE THERAPY- LONG TERM RESULTS FROM PHOENIX 1

    May 1, 2010, 00:00

  • PMS73 OPERATIVE RISK OF STAGED BILATERAL KNEE REPLACEMENT IS UNDER-ESTIMATED IN RETROSPECTIVE STUDIES

    May 1, 2010, 00:00

  • PMH37 CHARACTERISTICS OF HOSPITALIZATIONS FOR ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) AMONG CHILDREN AND ADOLESCENTS IN THE UNITED STATES FROM 2000-2006

    May 1, 2010, 00:00

  • PSY21 PROJECTING THE ECONOMIC OUTCOMES OF OBESITY USING A NATURAL HISTORY MODEL

    May 1, 2010, 00:00

  • PDB8 FEWER TREATMENT CHANGES WITH PREMIXED INSULIN ANALOGUES COMPARED TO PREMIXED HUMAN INSULIN-A REAL-LIFE TREATMENT PATTERN ANALYSIS OF PATIENTS WITH TYPE 2 DIABETES IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PDB18 COSTS OF DIABETES TREATMENT IN THE MEXICAN PRIVATE SECTOR

    May 1, 2010, 00:00

  • PDB72 POTENTIALLY PREVENTABLE HOSPITALIZATIONS FOR DIABETES COMPLICATIONS, CARE ORGANIZATION AND CONTINUITY OF CARE

    May 1, 2010, 00:00

  • PCV153 FAILURE OF THE BLAND-ALTMAN METHOD TO IDENTIFY CLINICALLY IMPORTANT DISAGREEMENT BETWEEN MEASURES OF THE INTERNATIONAL NORMALIZED RATIO

    May 1, 2010, 00:00

  • PCN152 TREATMENT PATTERNS IN ADULT PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES

    May 1, 2010, 00:00

  • PM1 RISK-BENEFIT FRAMEWORK FOR EVALUATION OF GENE EXPRESSION PROFILING IN WOMEN WITH EARLY STAGE BREAST CANCER- A DECISION MODEL DEVELOPED IN COLLABORATION WITH STAKEHOLDERS

    May 1, 2010, 00:00

  • PCV79 COST-EFFECTIVENESS OF DALTEPARIN IN THE MANAGEMENT OF UNSTABLE ANGINA/NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (UA/NSTEMI) EVENTS IN ADULT PATIENTS IN MEXICO

    May 1, 2010, 00:00

  • PIN28 COST-EFFECTIVENESS ANALYSIS OF CHANGING FROM LIVE ORAL POLIOVIRUS VACCINE TO INACTIVATED POLIOVIRUS VACCINE IN COLOMBIA

    May 1, 2010, 00:00

  • PCN61 THE COST-EFFECTIVENESS OF CETUXIMAB USE AMONG ELDERLY METASTATIC COLORECTAL CANCER PATIENTS

    May 1, 2010, 00:00

  • PMC23 A UNIVERSAL SCORING SYSTEM FOR EQ-5D - A VASTLY SIMPLER SOLUTION

    May 1, 2010, 00:00

  • PMS65 DERIVING DOCTORS PRESCRIBING PATTERNS FROM CLAIMS DATA- AN APPLICATION TO TNF AND NON-TNF BIOLOGICS

    May 1, 2010, 00:00

  • PCN5 ASSESSMENT OF NEUROPATHY IN CLAIMS DATA AND THE ASSOCIATION WITH DOCETAXEL (DC) AND PACLITAXEL (PC) IN ADJUVANT BREAST CANCER (BC)

    May 1, 2010, 00:00

  • PMH64 USE OF PATIENT SUPPORT SYSTEM TO INCREASE COMPLIANCE FOR OPIOID ADDICTED PATIENTS

    May 1, 2010, 00:00

  • PIH10 TREATMENT PATTERNS AND ECONOMIC BURDEN OF UTERINE FIBROIDS IN A UNITED STATES MANAGED CARE DATABASE

    May 1, 2010, 00:00

  • PSY58 US COST EFFECTIVENESS ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS ON-DEMAND TREATMENT IN HEMOPHILIA- DESIGN AND RATIONALE OF A COMPREHENSIVE MODEL

    May 1, 2010, 00:00

  • PMH24 ASSOCIATION OF ANTIDEPRESSANT THERAPY AND BIPOLAR DISORDER (BD)-RELATED RE-HOSPITALIZATIONS AMONG PATIENTS WITH MANIC OR MIXED BD EPISODES

    May 1, 2010, 00:00

  • PMH89 TRENDS IN U.S. OUTPATIENT PHYSICIAN VISITS AND MEDICATION TREATMENT PATTERNS FOR PEDIATRIC ADHD- 1998-2007

    May 1, 2010, 00:00

  • PHP84 OUTCOMES OF BEDSIDE-BARCODE TECHNOLOGY INTERVENTION ON MEDICATION ADMINISTRATION TIME IN AN INTENSIVE CARE UNIT

    May 1, 2010, 00:00

  • PHP16 LOW SOCIOECONOMIC STATUS IS A RISK FACTOR FOR CPAP ACCEPTANCE AMONG ADULT OSAS PATIENTS REQUIRING TREATMENT

    May 1, 2010, 00:00

  • PSS13 VALIDITY AND RELIABILITY OF THE VISUAL FUNCTION QUESTIONNAIRE UTILITY INDEX IN INDIVIDUALS WITH AGE-RELATED MACULAR DEGENERATION

    May 1, 2010, 00:00

  • PHP110 ASSESSING THE OUTCOME OF ELBOW SURGERY- DEVELOPMENT, VALIDATION AND RESPONSIVENESS OF THE PATIENT-REPORTED OXFORD ELBOW SCORE (OES)

    May 1, 2010, 00:00

  • PHP21 SOURCES OF MEDICATION FOR PATIENTS IN GENERAL MEDICINE

    May 1, 2010, 00:00

  • PSY49 IMPACT OF DISEASE ON CAREER CHOICES, ABSENTEEISM, AND WORK LOSS AMONG INDIVIDUALS WITH PSORIASIS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCV56 INCREMENTAL COSTS OF BLEEDING IN PATIENTS WITH ATRIAL FIBRILLATION WITHIN A LARGE, NATIONAL HEALTH PLAN

    May 1, 2010, 00:00

  • PCV73 CONSIDERING THE COST-EFFECTIVENESS OF STATINS IN FAMILY PRACTICE IN TURKEY FROM A PAYER PERSPECTIVE

    May 1, 2010, 00:00

  • PGI11 PEDIATRIC HOSPITALIZATIONS FOR INFLAMMATORY BOWEL DISEASE- RESULTS FROM 2006 KIDS INPATIENT DATABASE

    May 1, 2010, 00:00

  • PM3 ECONOMIC EVALUATION OF GENETIC TEST IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR AMNESTIC MILD COGNITIVE IMPAIRMENT PATIENTS- LIFE- TIME MODEL

    May 1, 2010, 00:00

  • PMH4 DEMOGRAPHIC RISK FACTORS AFFECTING BENZODIAZEPINE-RELATED EMERGENCY ROOM VISITS IN KANSAS CITY, MO FROM 2001 TO 2007

    May 1, 2010, 00:00

  • PCV45 BUDGET IMPACT OF BIVALIRUDIN IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) IN GERMAN HOSPITALS

    May 1, 2010, 00:00

  • PCV18 COST-UTILITY ANALYSIS OF TWO KINDS OF THERAPY FOR ACUTE ISCHEMIC STROKE

    May 1, 2010, 00:00

  • PIH15 COST EFFECTIVENESS ANALYSIS OF FDA APPROVED ORAL EMERGENCY CONTRACEPTIVES

    May 1, 2010, 00:00

  • PIN10 CLINICAL AND ECONOMIC OUTCOMES OF INVASIVE ASPERGILLOSIS (IA) IN THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) NON-TRADITIONAL HOST- A HOSPITAL DATABASE ANALYSIS

    May 1, 2010, 00:00

  • PCN51 HEALTH CARE COSTS ASSOCIATED WITH ANGIOGENESIS INHIBITORS (AIS) AND MTOR INHIBITORS (MTORS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED AT US COMMUNITY ONCOLOGY CLINICS

    May 1, 2010, 00:00

  • PND34 UTILIZATION, PRICE, AND EXPENDITURE TRENDS FOR ANTI-MIGRAINE DRUGS IN THE US MEDICAID PROGRAM FROM 1991 THROUGH 2008

    May 1, 2010, 00:00

  • PND10 THE AMERICA INSOMNIA SURVEY (AIS)- AN EPIDEMIOLOGY STUDY OF INSOMNIA PREVALENCE AND BURDEN IN A REPRESENTATIVE POPULATION

    May 1, 2010, 00:00

  • PCV10 A META-ANALYSIS OF CARDIOVASCULAR RISK FACTORS- WHICH IS THE DIFFERENCE BETWEEN MEN AND WOMEN?

    May 1, 2010, 00:00

  • PCN150 TRENDS IN USAGE AND UPTAKE OF TARGETED CANCER THERAPIES VERSUS CHEMOTHERAPIES

    May 1, 2010, 00:00

  • DB3 MUCH ADO ABOUT THE LACK OF SOCIO-ECONOMIC COVARIATES IN ADMINISTRATIVE CLAIMS DATA

    May 1, 2010, 00:00

  • PCV58 ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM IN US HOSPITALS

    May 1, 2010, 00:00

  • PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHNS DISEASE

    May 1, 2010, 00:00

  • PMH30 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS AT CLINICALLY RECOMMENDED DOSES BASED ON MEDICAID CLAIMS DATA FROM EIGHT STATES

    May 1, 2010, 00:00

  • PCV59 EXPLORING THE RELATIONSHIP OF COST SHARING AND FIXED-DOSE COMBINATION VERSUS MONO ANTIHYPERTENSIVE MEDICATION THERAPY AMONG HYPERTENSION PATIENTS

    May 1, 2010, 00:00

  • PHP57 MEDICATION USAGE BEHAVIOUR ASSESSMENT AMONGST OUTPATIENTS VISITING PUBLIC TEACHING HOSPITAL

    May 1, 2010, 00:00

  • PDB38 THE IMPACT OF DIABETES ON WORKPLACE PRESENTEEISM- A CROSS NATIONAL STUDY IN THE EUROPEAN UNION

    May 1, 2010, 00:00

  • PND5 COMPARISON OF DIRECT AND INDIRECT COSTS IN EMPLOYEES WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY TREATED WITH PREGABALIN OR DULOXETINE

    May 1, 2010, 00:00

  • PCN40 RETROSPECTIVE COST AND OUTCOME ANALYSIS OF BREAST CANCER PATIENTS TREATED IN A BRAZILIAN OUTPATIENT CANCER CENTER (OCC)

    May 1, 2010, 00:00

  • TR1 THE EFFECT OF GENERIC DRUG ENTRY ON U.S. MEDICAID EXPENDITURES- 1991-2008

    May 1, 2010, 00:00

  • PSS6 THE COST-EFFECTIVENESS OF ISOTRETINOIN IN PATIENTS WITH MODERATE-TO-SEVERE ACNE VULGARIS

    May 1, 2010, 00:00

  • PMS11 THE DIRECT MEDICAL COSTS OF RHEUMATOID ARTHRITIS- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PMH40 PATTERNS OF HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH GENERALIZED ANXIETY DISORDER INITIATING ADD-ON THERAPY WITH BENZODIAZEPINES

    May 1, 2010, 00:00

  • PUK24 THE IMPACT OF ADDING A RACIAL CASE MIX ADJUSTER TO MEDICARE DIALYSIS REMIBURSEMENT- CORRECTING A POTENTIAL BIAS

    May 1, 2010, 00:00

  • PCV46 A FRENCH HOSPITAL BUDGET IMPACT MODEL COMPARING ANTICOAGULATION STRATEGIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION

    May 1, 2010, 00:00

  • PDB22 HEALTH CARE COSTS AND RESOURCE UTILIZATION OF PATIENTS WITH TYPE 2 DIABETES MELLITUS WITHIN A NATIONAL US MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PCV20 VENOUS THROMBOEMBOLIC COMPLICATIONS IN BURN PATIENTS RECEIVING HEPARIN OR ENOXAPARIN AS PROPHYLAXIS

    May 1, 2010, 00:00

  • PMS15 COMPARISON OF MEDICAL RESOURCE USE AND COSTS ASSOCIATED WITH FIBROMYALGIA IN FRANCE, GERMANY AND THE UNITED STATES

    May 1, 2010, 00:00

  • PHP44 ANNUAL HEALTH INSURANCE COST OF SPA SERVICES IN HUNGARY

    May 1, 2010, 00:00

  • PHP109 THE ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN AMBULATORY SETTING IN GERMANY

    May 1, 2010, 00:00

  • PCV143 BELIEFS ABOUT ANTIHYPERTENSIVE MEDICATIONS IN PRIMARY CARE PATIENTS- VALIDATION OF BELIEFS ABOUT MEDICINES QUESTIONNAIRE (BMQ) IN COLOMBIA

    May 1, 2010, 00:00

  • PCV156 MODELING TRANSFORMED HEALTH CARE COSTS WITH UNKNOWN HETEROSKEDASTICITY

    May 1, 2010, 00:00

  • PSY8/CM3 PERSISTENCE WITH INFLIXIMAB MAINTENANCE THERAPY DECREASES HOSPITALIZATIONS IN PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2010, 00:00

  • PDB33 ECONOMIC EVALUATION OF THREE FIRST-LINE MEDICATIONS IN PAINFUL DIABETIC PERIPHERAL NEUROPHATY IN MEXICO

    May 1, 2010, 00:00

  • PUK13 THE COST-EFFECTIVENESS OF EARLY SURGERY, ADDING BIOPSY, AND WATCHFUL WAITING IN THE MANAGEMENT OF SMALL SOLID RENAL MASSES- EVIDENCE FROM A MARKOV MODEL

    May 1, 2010, 00:00

  • PCV138 ASSESSING THE IMPACT OF AN EMPLOYER SPONSORED COMMUNITY PHARMACY BASED MTM PROGRAM ON CLINICAL OUTCOMES FOR PATIENTS WITH DIABETES AND HYPERTENSION

    May 1, 2010, 00:00

  • PCV128 RELATIONSHIPS BETWEEN PHYSICAL INACTIVITY AND HEALTH CARE EXPENDITURE AND RESOURCE USE IN PATIENTS WITH PRIMARY HYPERTENSION

    May 1, 2010, 00:00

  • PCN147 CHARACTERISTICS OF POSTMENOPAUSAL WOMEN INITIATING RALOXIFENE BEFORE AND AFTER APPROVAL OF INVASIVE BREAST CANCER RISK REDUCTION INDICATIONS

    May 1, 2010, 00:00

  • PDB23 RESOURCE CONSUMPTION AND COSTS OF CARE THE YEAR BEFORE AND AFTER INITIATION OF INSULIN THERAPY IN SWEDISH PATIENTS WITH TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PND31 IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS RECEIVING NATALIZUMAB IN THE UNITED STATES

    May 1, 2010, 00:00

  • PRS33 TRANSLATING THE EXACT- ENSURING CONCEPTUAL EQUIVALENCE ACROSS MULTIPLE CULTURES

    May 1, 2010, 00:00

  • PHP81 UNITED STATES PHD PROGRAMS IN PHARMACOECONOMICS AND OUTCOMES RESEARCH

    May 1, 2010, 00:00

  • PGI23 COST EFFECTIVENESS ANALYSIS OF RIFAXIMIN FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY

    May 1, 2010, 00:00

  • PRS22 COST-BENEFIT ANALYSIS OF VARENICLINE VS. EXISTING SMOKING CESSATION STRATEGIES IN PREGNANT WOMEN

    May 1, 2010, 00:00

  • PMS5 MEDICAL COSTS FOLLOWED BY FALLS/SLIPS AT A TEACHING HOSPITAL IN JAPAN

    May 1, 2010, 00:00

  • PMC36 VALIDITY OF SELF-REPORT WITH RESPECT TO PRESCRIPTION MEDICATIONS AMONG PREGNANT WOMEN

    May 1, 2010, 00:00

  • PCV65 AN EXPLORATORY COST-CONSEQUENCE AND BUDGET IMPACT ANALYSIS OF SIROLIMUS-ELUTING STENT VS. PACLITAXEL-ELUTING STENT- THE IMPACT OF RESTENOSIS AFTER DRUG-ELUTING STENT PLACEMENT UNDER THE PRIVATE PAYERS PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCV93 DISCRETE EVENT SIMULATION OF CARDIAC HOSPITALS PERFORMING PERCUTANEOUS CORONARY INTERVENTIONS

    May 1, 2010, 00:00

  • PMH33 COMPARISON OF COSTS AND HEALTH CARE UTILIZATIONS IN PHARMACOTHERAPY, PSYCHOTHERAPY, AND COMBINED THERAPY GROUPS FOR TREATMENT OF DEPRESSION

    May 1, 2010, 00:00

  • PCN46 FIRST YEAR INSURER AND PATIENT COSTS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DIAGNOSIS IN THE U.S. MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PRS6 EFFECT OF NICOTINE GUM PRICE ON MEDICATION ACQUISITION AND SMOKING CESSATION IN AN OVER-THE-COUNTER SETTING

    May 1, 2010, 00:00

  • PCN92 VALUATION OF CLINICO-ECONOMIC EFFECTIVNESS OF THEATMENT OF CHILDREN WITH THE NON-HODGKIN LYMPHOMAS (NHLS) ACCORDING TO THE NHL-BFM-95 PROTOCOL

    May 1, 2010, 00:00

  • PCN120 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LUNG CANCER TREATMENT IN KOREA

    May 1, 2010, 00:00

  • PCV63 ECONOMIC IMPACT OF SWITCHING FROM VALSARTAN TO OTHER ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) IN PATIENTS WITH HYPERTENSION

    May 1, 2010, 00:00

  • PMC4 THE DERIVATION OF TRICARE SPECIFIC CONSUMER PRICE INDICES FOR PRESCRIPTION DRUGS

    May 1, 2010, 00:00

  • PUK17 THE VALUE OF HYPERTENSION CONTROL TO CHRONIC KIDNEY DISEASE PREVENTION

    May 1, 2010, 00:00

  • PCV12 TRENDS IN C-REACTIVE PROTEIN SCREENING PRIOR TO STATIN USE IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN99 ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKAEMIA IN PATIENTS RESISTANT TO IMATINIB IN COLOMBIA AND VENEZUELA

    May 1, 2010, 00:00

  • PIN39 A RETROSPECTIVE EVALUATION OF PATIENT ADHERENCE TO ANTIRETROVIRAL THERAPY- PROPORTION OF DAYS COVERED VERSUS MEDICATION POSSESSION RATIO

    May 1, 2010, 00:00

  • PDB9 DIABETES RISK ASSESSMENT-APPLICATION AND VALIDATION OF A DIABETES SCREENING SCORE APPLIED TO THE NATIONAL HEALTH AND WELLNESS SURVEY

    May 1, 2010, 00:00

  • PHP99 DESCRIPTION AND EVALUATION OF THE KNOWLEDGE OF THE BRASILIA POPULATION FOR THE POLITICS OF ECONOMIC MEDICINE REGULATION IN BRAZIL

    May 1, 2010, 00:00

  • PGI18 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPE I CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCN153 TREATMENT PATTERNS OF MEXICAN ONCOLOGISTS IN FIVE DIFFERENT MALIGNANCIES- A SURVEY

    May 1, 2010, 00:00

  • PCV106 PREDICTORS OF CLOPIDOGREL USE AND ADHERENCE FOR PATIENTS WITH ACUTE CORONARY SYNDROMES IN A LARGE EMPLOYER-BASED CLAIMS DATABASE

    May 1, 2010, 00:00

  • PIH22 CONSTRUCT VALIDITY OF THE BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX

    May 1, 2010, 00:00

  • PMC41 PATIENT-REPORTED OUTCOMES IN CLINICAL RESEARCH- PRESENT STATUS AND A LOOK TO THE FUTURE

    May 1, 2010, 00:00

  • PCV78 A PHARMACOECONOMICS ASSESSMENT OF SILDENAFIL IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION IN PEDIATRICS- THE MEXICAN CASE

    May 1, 2010, 00:00

  • PIH36 BILLING PATTERNS FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER

    May 1, 2010, 00:00

  • PIN20 ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE WITHIN THE PRIVATE MARKET IN BRAZIL

    May 1, 2010, 00:00

  • PR1 INCORPORATING TARIFF-LEVEL UNCERTAINTY AROUND ESTIMATES FROM THE CATALOGUE OF EQ-5D SCORES

    May 1, 2010, 00:00

  • PUK12 ECONOMIC EVALUATION ON THE USE OF OXYBUTYNIN, TOLTERODINE, AND SOLIFENACIN IN PATIENTS WITH HYPERACTIVE BLADDER

    May 1, 2010, 00:00

  • PHP83 QUALITY ASSURANCE OF FOURTH HURDLE WITHIN THE SLOVAK REPUBLIC

    May 1, 2010, 00:00

  • PSY27 COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN ARGENTINA

    May 1, 2010, 00:00

  • PDB6 RELATIVE EFFECTIVENESS MANAGEMENT OF TYPE II DIABETES IN EUROPE- CAN THE AGENCIES DEMANDS BE MET?

    May 1, 2010, 00:00

  • PRS31 RELATIONSHIP BETWEEN DAILY DOSING FREQUENCY, COMPLIANCE, HEALTH CARE RESOURCE USE, AND COSTS- EVIDENCE FROM THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

    May 1, 2010, 00:00

  • PCN138 THE FINANCIAL EFFECT OF THE INTRODUCTION OF PERFORMANCEVOLUME LIMIT (PVL) ON THE HUNGARIAN ONCOLOGY CARE

    May 1, 2010, 00:00

  • PMS3 A BAYESIAN ANALYSIS OF BISPHOSPHONATE EFFICACY FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS

    May 1, 2010, 00:00

  • CN1 MODELING THE IMPACT OF TECHNOLOGY DIFFUSION IN BREAST CANCER TREATMENT ON THE COST-EFFECTIVENESS OF MAMMOGRAPHY SCREENING

    May 1, 2010, 00:00

  • PDB50 THE IMPACT OF OBESITY AND QUALTY OF LIFE ON MEDICAL AND LOST PRODUCTIVITY COSTS IN DIABETIC PATIENTS

    May 1, 2010, 00:00

  • PCN49 COSTS TO MEDICARE OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH ALEMTUZUMAB

    May 1, 2010, 00:00

  • PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)- RESULTS FROM A MEDICAL CHART REVIEW STUDY

    May 1, 2010, 00:00

  • PIN14 REDUCTION OF ACUTE OTITIS MEDIA IN CHILDREN- A COST-CONSEQUENCE ANALYSIS OF A 7-, 10-AND 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CANADA

    May 1, 2010, 00:00

  • PND30 NATALIZUMAB TREATMENT IS ASSOCIATED WITH AN IMPROVEMENT IN PATIENT-REPORTED FATIGUE AND COGNITIVE FUNCTION OVER TIME

    May 1, 2010, 00:00

  • UT4 EVALUATING WILLINGNESS TO PAY THRESHOLDS FOR A DEMENTIA CAREGIVING INTERVENTION

    May 1, 2010, 00:00

  • PIN23 COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE POLYVALENT (PPSV23) IN ADULTS OLDER THAN 60 YEARS OLD IN COLOMBIA

    May 1, 2010, 00:00

  • PCV70 COST-EFFECTIVENESS OF ROSUVASTATIN 20 MG IN SECONDARYPREVENTION PATIENTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PSY11 THE INDIRECT COSTS OF INFLAMMATORY BOWEL DISEASE- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PDB21 MEDICAL COST AND SETTLEMENT PATTERN STUDY ON DIABETES MELLITUS INSURANTS IN CHINA

    May 1, 2010, 00:00

  • PCN6 EVALUATION OF THE RELIABILITY OF ELECTRONIC MEDICAL RECORD DATA IN IDENTIFYING COMORBID CONDITIONS AMONG PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2010, 00:00

  • PHP3 EFFECTIVENESS OF A PATIENT PERSISTENCY PROGRAM TO INCREASE COMPLIANCE FOR VACCINATION

    May 1, 2010, 00:00

  • PND1 CLINICAL AND PHARMACY UTILIZATION OUTCOMES WITH BRAND TO GENERIC ANTIEPILEPTIC UTILIZATION IN PATIENTS WITH EPILEPSY

    May 1, 2010, 00:00

  • PMH52 ECONOMIC ANALYSIS OF ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD)

    May 1, 2010, 00:00

  • PHP54 STUDY THE IMPACT OF AUTOREFILL PROGRAM ON MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PCN115 HEAD-TO-HEAD COMPARISONS OF QUALITY OF LIFE INSTRUMENTS FOR YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER

    May 1, 2010, 00:00
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138 (current)
  • 139
  • 140
  • »